Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/23228| Title: | Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again? | Austin Authors: | O'Connor, Ellen ;Teh, Jiasian ;Kamat, Ashish M;Lawrentschuk, Nathan | Affiliation: | Department of Urology, The Royal Melbourne Hospital, Melbourne, Victoria, Australia Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Department of Urology, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA |
Issue Date: | Jul-2020 | Date: | 2020-05-14 | Publication information: | Future oncology (London, England) 2020; 16(19): 1323-1325 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/23228 | DOI: | 10.2217/fon-2020-0381 | ORCID: | 0000-0001-8553-5618 0000-0001-8576-586X 0000-0002-7882-5155 |
Journal: | Future oncology (London, England) | PubMed URL: | 32406253 | Type: | Journal Article | Subjects: | BCG vaccine COVID-19 clinical trials coronavirus immunotherapy mycobacterium bovis |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.